-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The dosage forms of the current domestic declaration consistency evaluation include tablets (2 over-reviewed, 3 in review), slow-release tablets (1 over-reviewed, 2 in review), slow-release capsules (1 over-reviewed, 1 in review).
there is no injection consistency evaluation reporting enterprises.
source: Pharmaceutical Rubik's Cube PharmaGo mononitric acid iso-sorbate is a nitrate lipid drug, is an important NO exogenetic supply.
can be divided into 5-single nitrate isosor ester and 2-mononitric acid iso-sorbate, clinically commonly used is 5-mononitric acid iso-sorbital ester.
The variety of intravenous drip injection is slow, the best way to administer medicine is oral, oral and intravenous bio-utilization is 100%, and oral effectiveness time is faster than intravenous injection, so the dosage form is mostly oral dosage form.
slow release dosage forms are suitable for long-term treatment of coronary heart disease, prevention of angina, treatment of persistent angina after myocardial infarction, and combined application with arterial yellow and/or diuretics to treat chronic congestive heart failure.
And other types of nitrate drugs include: dinitrate isosorbate, the best way to administer the drug is intravenously, oral biological utilization is very low, not recommended oral;
。